BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 37177980)

  • 21. Risk of second malignancies among survivors of pediatric thyroid cancer.
    Adly MH; Sobhy M; Rezk MA; Ishak M; Afifi MA; Shafie AE; Ali MA; Zekri W; Alfaar AS; Rashed WM
    Int J Clin Oncol; 2018 Aug; 23(4):625-633. PubMed ID: 29492793
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Male Breast Cancer as a Second Primary Cancer: Increased Risk Following Lymphoma.
    Farr DE; Thomas A; Khan SA; Schroeder MC
    Oncologist; 2017 Aug; 22(8):895-900. PubMed ID: 28487463
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk of Second Primary Malignancies in Patients With Follicular Lymphoma: A United States Population-based Study.
    Giri S; Bhatt VR; Verma V; Pathak R; Bociek RG; Vose JM; Armitage JO
    Clin Lymphoma Myeloma Leuk; 2017 Sep; 17(9):569-574. PubMed ID: 28709798
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Temporal patterns in the risk of chronic health conditions in survivors of childhood cancer diagnosed 1970-99: a report from the Childhood Cancer Survivor Study cohort.
    Gibson TM; Mostoufi-Moab S; Stratton KL; Leisenring WM; Barnea D; Chow EJ; Donaldson SS; Howell RM; Hudson MM; Mahajan A; Nathan PC; Ness KK; Sklar CA; Tonorezos ES; Weldon CB; Wells EM; Yasui Y; Armstrong GT; Robison LL; Oeffinger KC
    Lancet Oncol; 2018 Dec; 19(12):1590-1601. PubMed ID: 30416076
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Second malignancies after childhood noncentral nervous system solid cancer: Results from 13 cancer registries.
    Maule M; Scélo G; Pastore G; Brennan P; Hemminki K; Olsen JH; Tracey E; Pukkala E; Weiderpass E; Brewster DH; Tamaro S; Chia KS; Pompe-Kirn V; Kliewer EV; Tonita JM; Martos C; Jonasson JG; Merletti F; Boffetta P
    Int J Cancer; 2011 Oct; 129(8):1940-52. PubMed ID: 21520035
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Secondary sarcomas in childhood cancer survivors: a report from the Childhood Cancer Survivor Study.
    Henderson TO; Whitton J; Stovall M; Mertens AC; Mitby P; Friedman D; Strong LC; Hammond S; Neglia JP; Meadows AT; Robison L; Diller L
    J Natl Cancer Inst; 2007 Feb; 99(4):300-8. PubMed ID: 17312307
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Late mortality, secondary malignancy and hospitalisation in teenage and young adult survivors of Hodgkin lymphoma: report of the Childhood/Adolescent/Young Adult Cancer Survivors Research Program and the BC Cancer Agency Centre for Lymphoid Cancer.
    Bhuller KS; Zhang Y; Li D; Sehn LH; Goddard K; McBride ML; Rogers PC
    Br J Haematol; 2016 Mar; 172(5):757-68. PubMed ID: 26727959
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk of subsequent primary oral cancer in a cohort of 69,460 5-year survivors of childhood and adolescent cancer in Europe: the PanCareSurFup study.
    Sunguc C; Hawkins MM; Winter DL; Dudley IM; Heymer EJ; Teepen JC; Allodji RS; Belle FN; Bagnasco F; Byrne J; Bárdi E; Ronckers CM; Haddy N; Gudmundsdottir T; Garwicz S; Jankovic M; van der Pal HJH; Mazić MČ; Schindera C; Grabow D; Maule MM; Kaatsch P; Kaiser M; Fresneau B; Michel G; Skinner R; Wiebe T; Sacerdote C; Jakab Z; Gunnes MW; Terenziani M; Winther JF; Lähteenmäki PM; Zaletel LZ; Kuehni CE; Kremer LC; Haupt R; de Vathaire F; Hjorth L; Reulen RC
    Br J Cancer; 2023 Jan; 128(1):80-90. PubMed ID: 36319851
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bone and Soft-Tissue Sarcoma Risk in Long-Term Survivors of Hereditary Retinoblastoma Treated With Radiation.
    Kleinerman RA; Schonfeld SJ; Sigel BS; Wong-Siegel JR; Gilbert ES; Abramson DH; Seddon JM; Tucker MA; Morton LM
    J Clin Oncol; 2019 Dec; 37(35):3436-3445. PubMed ID: 31622129
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term risks of subsequent primary neoplasms among survivors of childhood cancer.
    Reulen RC; Frobisher C; Winter DL; Kelly J; Lancashire ER; Stiller CA; Pritchard-Jones K; Jenkinson HC; Hawkins MM;
    JAMA; 2011 Jun; 305(22):2311-9. PubMed ID: 21642683
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Secondary hematopoietic malignancies in survivors of childhood cancer: an analysis of 111 cases from the Surveillance, Epidemiology, and End Result-9 registry.
    Rihani R; Bazzeh F; Faqih N; Sultan I
    Cancer; 2010 Sep; 116(18):4385-94. PubMed ID: 20549819
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin's disease: report from the Late Effects Study Group.
    Bhatia S; Yasui Y; Robison LL; Birch JM; Bogue MK; Diller L; DeLaat C; Fossati-Bellani F; Morgan E; Oberlin O; Reaman G; Ruymann FB; Tersak J; Meadows AT;
    J Clin Oncol; 2003 Dec; 21(23):4386-94. PubMed ID: 14645429
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Melanoma as a subsequent neoplasm in adult survivors of childhood cancer: a report from the childhood cancer survivor study.
    Pappo AS; Armstrong GT; Liu W; Srivastava DK; McDonald A; Leisenring WM; Hammond S; Stovall M; Neglia JP; Robison LL
    Pediatr Blood Cancer; 2013 Mar; 60(3):461-6. PubMed ID: 22887858
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New primary neoplasms of the central nervous system in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study.
    Neglia JP; Robison LL; Stovall M; Liu Y; Packer RJ; Hammond S; Yasui Y; Kasper CE; Mertens AC; Donaldson SS; Meadows AT; Inskip PD
    J Natl Cancer Inst; 2006 Nov; 98(21):1528-37. PubMed ID: 17077355
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Second Cancer Risk Up to 40 Years after Treatment for Hodgkin's Lymphoma.
    Schaapveld M; Aleman BM; van Eggermond AM; Janus CP; Krol AD; van der Maazen RW; Roesink J; Raemaekers JM; de Boer JP; Zijlstra JM; van Imhoff GW; Petersen EJ; Poortmans PM; Beijert M; Lybeert ML; Mulder I; Visser O; Louwman MW; Krul IM; Lugtenburg PJ; van Leeuwen FE
    N Engl J Med; 2015 Dec; 373(26):2499-511. PubMed ID: 26699166
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Second primary malignancy in diffuse large B-cell lymphoma patients: A SEER database analysis.
    Jiang S; Zhen H; Jiang H
    Curr Probl Cancer; 2020 Feb; 44(1):100502. PubMed ID: 31537411
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.
    Huang KP; Weinstock MA; Clarke CA; McMillan A; Hoppe RT; Kim YH
    Arch Dermatol; 2007 Jan; 143(1):45-50. PubMed ID: 17224541
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Second malignancies after adjuvant radiation therapy for early stage breast cancer: is there increased risk with addition of regional radiation to local radiation?
    Hamilton SN; Tyldesley S; Li D; Olson R; McBride M
    Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):977-85. PubMed ID: 25832690
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Trends in the Risks of Secondary Cancers in Patients With Hodgkin Lymphoma.
    Kumar V; Garg M; Chandra AB; Mayorga VS; Ahmed S; Ailawadhi S
    Clin Lymphoma Myeloma Leuk; 2018 Sep; 18(9):576-589.e1. PubMed ID: 29934060
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risks of second malignancies after breast cancer treatment: Long-term results.
    Bazire L; De Rycke Y; Asselain B; Fourquet A; Kirova YM
    Cancer Radiother; 2017 Feb; 21(1):10-15. PubMed ID: 28034681
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.